The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience.
 
Filip Ionescu
No Relationships to Disclose
 
Parth Patel
No Relationships to Disclose
 
Shrinjaya Thapa
No Relationships to Disclose
 
Dimitrios Drekolias
No Relationships to Disclose
 
Brandon Jamaal Blue
No Relationships to Disclose
 
Omar Alexis Castaneda Puglianini
Speakers' Bureau - Adaptive Biotechnologies
 
Jose L. Ochoa-Bayona
No Relationships to Disclose
 
Ciara L. Freeman
No Relationships to Disclose
 
Hien Liu
No Relationships to Disclose
 
Doris K. Hansen
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Bristol-Myers Squibb/Celgene
 
Taiga Nishihori
Research Funding - Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Ariosto Silva
No Relationships to Disclose
 
Praneeth Reddy Sudalagunta
No Relationships to Disclose
 
Jason B. Brayer
Employment - Janssen
 
Melissa Alsina
Honoraria - Janssen
Consulting or Advisory Role - BMS; Janssen Oncology
Speakers' Bureau - Janssen Oncology
 
Kenneth H. Shain
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - AbbVie
 
Rachid C. Baz
Consulting or Advisory Role - Abbvie; BMS; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Shattuck Labs
Research Funding - Abbvie (Inst); BMS (Inst); Celgene (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst); Signal Genetics (Inst); Takeda (Inst)
Other Relationship - GlaxoSmithKline
 
Ariel Felipe Grajales-Cruz
Consulting or Advisory Role - Cellectar; Sanofi
Speakers' Bureau - Amgen; Sanofi